WHO Endorses Protocol For COVID-19 Herbal Solutions


The World Health Organization (WHO), has endorsed a protocol for testing African herbal medicines as potential treatments for the coronavirus and other epidemics.

COVID-19 has raised the issue of using traditional medicines to battle contemporary diseases, and the endorsement clearly encouraged testing with criteria similar to those used for molecules developed by labs in Asia, Europe or the Americas.

It came months after a bid by the president of Madagascar to promote a drink based on artemisia, a plant with proven efficacy in malaria treatment, was met with widespread scorn.

On Saturday, WHO experts and colleagues from two other organisations in a statement, “endorsed a protocol for phase III clinical trials of herbal medicine for COVID-19 as well as a charter and terms of reference for the establishment of a data and safety monitoring board for herbal medicine clinical trials.”

The statement noted that, “Phase III clinical trials are pivotal in fully assessing the safety and efficacy of a new medical product.”

Also, Prosper Tumusiime, a regional WHO director, said, “If a traditional medicine product is found to be safe, efficacious and quality-assured, WHO will recommend (it) for a fast-tracked, large-scale local manufacturing.”

WHO’s partners are the Africa Centre for Disease Control and Prevention and the African Union Commission for Social Affairs.

Tumusiime added, “The onset of Covid-19, like the Ebola outbreak in West Africa, has highlighted the need for strengthened health systems and accelerated research and development programmes, including on traditional medicines.”

Comments are closed.